| Liver Cirrhosis |
NCT02120196: Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis |
|
|
| Recruiting | 3 | 100 | RoW | Rifaximin, Gastrobiotic, Trencedia, Norfloxacin, Epinor | Sherief Abd-Elsalam, Tanta University | Spontaneous Bacterial Peritonitis, Ascites, Liver Cirrhosis | 12/23 | 12/23 | | |
NCT02011932: Prospective Observational Study of Disease Progression in Chronic Hepatitis C |
|
|
| Active, not recruiting | N/A | 133 | RoW | | Beijing YouAn Hospital | Hepatitis C, Chronic, Disease Progression, Liver Cirrhosis | 06/11 | 07/30 | | |
| No Longer Available | N/A | | Europe, RoW | Telaprevir + peginterferon alfa + ribavirin, experimental, peginterferon alfa + ribavirin | Janssen-Cilag International NV | Hepatitis C | | | | |
|
|
|
|
|
|
|
|
|
NCT02161939: A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C |
|
|
| No Longer Available | N/A | | US | Daclatasvir (BMS-790052), Sofosbuvir | Bristol-Myers Squibb | Chronic Hepatitis C | | | | |
|
| Recruiting | N/A | 200 | Europe | | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Liver Cirrhosis | 12/16 | 12/26 | | |
NCT01306071: Observational Study of Persons With Hepatitis B Virus Infection in North America |
|
|
| Recruiting | N/A | 200 | US | | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative | | | | |
| Recruiting | N/A | 2000 | Europe | Fibrosis Biomarkers, AST:ALT ratio, APRI, BARD score, ELF Score, FIB4, NAFLD Fibrosis Score,Transient Elastography | University of Nottingham | Chronic Liver Disease, Alcohol Use Disorder, Type 2 Diabetes, Persistently Elevated ALT, Obesity | 05/33 | 05/33 | | |